Blood DNA test in newly diagnosed head and neck cancer
Part of Cancer clinical trials.
This study looks at “circulating tumor DNA” (tumor DNA found in blood) in people with newly diagnosed, locally advanced head and neck squamous cell cancer. Researchers want to see how the blood DNA levels relate to the cancer and how it may guide treatment after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old and can sign consent, including permission to share health records for the study
- You have newly diagnosed squamous cell cancer in the mouth, throat, or larynx (voice box)
- You plan to have the main tumor fully removed with curative intent at UNC-CH
- Your cancer has not spread to distant organs (no metastatic disease, M0)
- You have needed tumor samples available for study testing, and you can do repeated blood draws
- You can receive recommended after-surgery treatment (radiation and sometimes other medicines) as your doctors advise
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test (called a liquid biopsy) to better understand and predict the course of head and neck cancers that have come back or spread. If you join, researchers will use a special chip to look at your immune cells and tumor cells in your blood.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study uses a simple blood test to look for leftover cancer DNA after treatment for head and neck squamous cell carcinoma. The goal is to see if the test can find very small amounts of cancer early, which might help doctors make better decisions about follow-up care.
This trial uses a blood test to look for tiny bits of tumor DNA after treatment for head and neck cancer. It aims to see if this test can detect any remaining cancer cells early, so you and your doctor can make informed decisions.
This study looks at specific genetic “methylation” patterns in people with head and neck squamous cell carcinoma. The results may help doctors understand the disease better and identify who may benefit from future treatments.
This study uses a blood test to see whether cancer DNA is still detectable after a stronger combination of radiation and chemotherapy for locally advanced head and neck cancer. The goal is to predict who may have “residual” (remaining) disease and help guide future care.
Hear when a new Head and Neck Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.